Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Bingqian Jiang, Yanmin Zhao, Yi Luo, Jian Yu, Yi Chen, Baodong Ye, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi

Blood (2023) 142 (Supplement 1): 2243.

https://doi.org/10.1182/blood-2023-182809

Published: 2023

Journal Articles

Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age

Hengwei Wu, Zhiyang Yuan, Xiang Xu, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, Zhongzheng Zheng, He Huang, Yanmin Zhao

Blood (2023) 142 (Supplement 1): 366.

https://doi.org/10.1182/blood-2023-184465

Published: 2023

Journal Articles

Assessment of 2022 European Leukemianet Risk Classification System in FLT3-ITD Positive Real-World Cohort from China

Enbo Chen, Jian Ge, Changqing Jiao, Jian Yu, Zhonghui Wu

Blood (2023) 142 (Supplement 1): 4226.

https://doi.org/10.1182/blood-2023-179835

Published: 2023

Journal Articles

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Mingyue Pan, Yibo Wu, Luxin Yang, Jimin Shi, Xiaoyu Lai, Lizhen Liu, Yanmin Zhao, Jian Yu, Sun Jie, Weiyan Zheng, Wenjun Wu, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 6977.

https://doi.org/10.1182/blood-2023-186211

Published: 2023

Journal Articles

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Blood (2023) 142 (Supplement 1): 2228.

https://doi.org/10.1182/blood-2023-184668

Published: 2023

Journal Articles

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Xiaolin Yuan, Yibo Wu, Xiaoyu Lai, Luxin Yang, Jimin Shi, Lizhen Liu, Jian Yu, Yanmin Zhao, Weiyan Zheng, Wenjun Wu, Yi Zhao, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7037.

https://doi.org/10.1182/blood-2023-189289

Published: 2023

Journal Articles

Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study

Fangshu Guan, Luxin Yang, Panpan Zhu, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yi Zhao, Jianping Lan, Yi Chen, Ying Lu, Guifang Ouyang, Yang Xu, Xi Qiu, Zhen Cai, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7056.

https://doi.org/10.1182/blood-2023-184478

Published: 2023

Journal Articles

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Meng Liu, Xiaoli Wang, Yi Luo, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi

Blood (2023) 142 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2023-184513

Published: 2023

Journal Articles

Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral Blood

Xiangjun Zeng, Jimei Ge, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Yamin Tan, Huarui Fu, Pengxu Qian, He Huang, Yanmin Zhao

Blood (2023) 142 (Supplement 1): 4890.

https://doi.org/10.1182/blood-2023-186179

Published: 2023

Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Blood (2023) 142 (Supplement 1): 3579.

https://doi.org/10.1182/blood-2023-189068

Published: 2023

Journal Articles

Sequential Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) for the Third-Line Salvage Treatment of Steroid-Refractory Acute GvHD: A Multicenter, Open Label, Phase 1b/2 Trial

Yanmin Zhao, Yi Luo, Jimin Shi, Jian Yu, Lizhen Liu, Xiaoyu Lai, Huarui Fu, Yishan Ye, Nainong Li, Erlie Jiang, Jundong Gu, Zhibo Han, Zhongchao Han, He Huang

Blood (2023) 142 (Supplement 1): 3486.

https://doi.org/10.1182/blood-2023-185274

Published: 2023

Journal Articles

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Wei Ping Liu, Bo Jiang, Yue Rong Shuang, Xing Zhao, Xuan Fan Zhong, Ying Tan, Guo Jian Yu, Sheng Jie Xue, Wu Zhong Shen, Gui Yun Tu, Zheng Yang, Han Yang Chen, Jason Xu, Shui Liu, Xiao Qiang Qiang Yan, Jun Zhu, Yu Qin Song

Blood (2023) 142 (Supplement 1): 6158.

https://doi.org/10.1182/blood-2023-188071

Published: 2023

Journal Articles

Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation during the Omicron Wave: A Single-Center Study

Panpan Zhu, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yishan Ye, Yibo Wu, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7111.

https://doi.org/10.1182/blood-2023-179826

Published: 2023

Journal Articles

C/EBPα-p30 Confers AML Cell Susceptibility to the Terminal Unfolded Protein Response and Resistance to Venetoclax By Activating DDIT3 Transcription

Mengbao Du, Mowang Wang, Meng Liu, Shan Fu, Yu Lin, Jian Yu, Xiaohong Yu, He Huang, Haowen Xiao, Limengmeng Wang

Blood (2022) 140 (Supplement 1): 3077–3079.

https://doi.org/10.1182/blood-2022-166249

Published: 2022

Journal Articles

Interpreting Immune Reconstitution and Clinical Outcome By Single-Cell Transcriptomic Analysis in T-ALL Patients Undergoing Donor-Derived CD7 CAR-T Immunotherapy

Hui Shi, Kai Hu, Fan Yang, Zhuojun Liu, Jia Liu, Wei Chen, Jian Yu

Blood (2022) 140 (Supplement 1): 10422–10423.

https://doi.org/10.1182/blood-2022-165035

Published: 2022

Journal Articles

Risk Factors and Prediction Model of Early Relapse in Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Xiaolin Yuan, Xiaoyu Lai, Yibo Wu, Luxin Yang, Jimin Shi, Lizhen Liu, Yanmin Zhao, Jian Yu, He Huang, Yi Luo

Blood (2022) 140 (Supplement 1): 12915.

https://doi.org/10.1182/blood-2022-168669

Published: 2022

Journal Articles

Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Luxin Yang, Xiaoyu Lai, Ting Yang, Ying Lu, Lizhen Liu, Jimin Shi, Yanmin Zhao, Yibo Wu, Yi Chen, Jian Yu, Haowen Xiao, Guifang Ouyang, Jinhua Ren, Junjie Cao, Yongxian Hu, Yamin Tan, Zhen Cai, He Huang, Yi Luo

Blood (2022) 140 (Supplement 1): 7676–7677.

https://doi.org/10.1182/blood-2022-166759

Published: 2022

Journal Articles

Double Filtration Plasmapheresis for Desensitization during Haploidentical Stem Cell Transplantation in Patients with Positive Donor-Specific Anti-HLA Antibodies

Lizhen Liu, Xinyu Ji, Panpan Zhu, Luxin Yang, Jimin Shi, Yanmin Zhao, Xiaoyu Lai, Jian Yu, Huarui Fu, Yishan Ye, Yibo Wu, He Huang, Yi Luo

Blood (2022) 140 (Supplement 1): 7594.

https://doi.org/10.1182/blood-2022-165972

Published: 2022

Journal Articles

MRD Monitoring of Non-DTA Genes By Digital Droplet PCR in the Early Period after Allogeneic Hematopoietic Stem Cell Transplantation Can Effectively Predict Patients at High Risk of Relapse

Weihao Chen, Luo Huang, Zhuoyue Shi, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Zhongzheng Zheng, He Huang, Yanmin Zhao

Blood (2022) 140 (Supplement 1): 4816–4818.

https://doi.org/10.1182/blood-2022-166696

Published: 2022

Journal Articles

Application of Metagenomic Next Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens from Bronchoalveolar Lavage Samples in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Jian Yu, Yingying Shi, Yanmin Zhao, Yishan Ye, Huarui Fu, Yi Luo, Xiaoyu Lai, Lizhen Liu, Li Yang, Meng Liu, He Huang, Jimin Shi

Blood (2022) 140 (Supplement 1): 12826–12828.

https://doi.org/10.1182/blood-2022-166049

Published: 2022

NARROW

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Deciphering the Impact of Donor Telomere Length on Allogeneic Transplantation Outcomes: Telomere Length Matters More Than Age

Assessment of 2022 European Leukemianet Risk Classification System in FLT3-ITD Positive Real-World Cohort from China

Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Biological and Therapeutic Implications of NPM1 -Mutated AML Receiving Allogeneic Hematopoietic Cell Transplantation

Comparison of Long-Term Outcome between Imatinib and Dasatinib Prophylaxis after Allogeneic Stem Cell Transplantation in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia-a Multi-Center Retrospective Study

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Constructing a Machine Learning-Based Rating Model to Predict the Outcome of GCSF Mobilization of Hematopoietic Stem Cells in Peripheral Blood

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Sequential Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) for the Third-Line Salvage Treatment of Steroid-Refractory Acute GvHD: A Multicenter, Open Label, Phase 1b/2 Trial

Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation during the Omicron Wave: A Single-Center Study

C/EBPα-p30 Confers AML Cell Susceptibility to the Terminal Unfolded Protein Response and Resistance to Venetoclax By Activating DDIT3 Transcription

Interpreting Immune Reconstitution and Clinical Outcome By Single-Cell Transcriptomic Analysis in T-ALL Patients Undergoing Donor-Derived CD7 CAR-T Immunotherapy

Risk Factors and Prediction Model of Early Relapse in Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Double Filtration Plasmapheresis for Desensitization during Haploidentical Stem Cell Transplantation in Patients with Positive Donor-Specific Anti-HLA Antibodies

MRD Monitoring of Non-DTA Genes By Digital Droplet PCR in the Early Period after Allogeneic Hematopoietic Stem Cell Transplantation Can Effectively Predict Patients at High Risk of Relapse

Application of Metagenomic Next Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens from Bronchoalveolar Lavage Samples in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only